stella
beta
Development of a cfDNA 5mC/5hmC-based Biomarker Panel to Predict Targeted Therapy Efficacy in mCRC — Stella
Home
/
CRC (Colorectal Cancer)
/
Development of a cfDNA 5mC/5hmC-based Biomarker Panel to Predict Targeted Therapy Efficacy in mCRC
View on ClinicalTrials.gov
Recruiting
Back to CRC (Colorectal Cancer) trials
Development of a cfDNA 5mC/5hmC-based Biomarker Panel to Predict Targeted Therapy Efficacy in mCRC
Trial locations
(1 site)
United States
City of Hope Medical Center, Duarte, California